Study of Muscle Mass and Diabetic Neuropathy in Adults with Type 2 Diabetes Aged 45 and Older

What this Trial Is About

This research aims to explore the connection between diabetic neuropathy and muscle mass in patients with type 2 diabetes mellitus who are aged 45 years or older. The study focuses on understanding how diabetic nerve damage relates to muscle loss and weakness, which may contribute to sarcopenia, a condition involving reduced muscle mass and function. The research involves patients with type 2 diabetes to assess this important health relationship. Participants will undergo several assessments to measure muscle mass and function. Ultrasound will be used to measure the thickness of the anterior thigh muscle and adjust it according to body mass index to estimate muscle mass. Clinical tests like hand grip strength and chair stand tests will evaluate muscle power. Nerve conduction studies will assess diabetic neuropathy in the lower limbs. These tests are scheduled over three weeks neurological exams and performance tests on day 1, nerve studies two weeks later, and muscle ultrasound in the third week. During the study, participants will have neurological and physical performance assessments, nerve conduction studies, and ultrasound imaging to measure muscle thickness. Researchers will evaluate sarcopenia by combining muscle mass and function data and analyze its relationship with diabetic neuropathy. The study period includes these assessments over a few weeks, with careful monitoring of muscle and nerve health. Participation involves attending these evaluations as scheduled to help researchers understand the link between muscle health and diabetic nerve damage.

The Relation Between Diabetic Neuropathy and Muscle Mass in Type 2 Diabetes Mellitus Patients